Browse Topic
Research
-
December 05, 2022
Canine cancer patient gets new lease on life while helping people fighting same disease
A partnership between UC Davis Comprehensive Cancer Center and UC Davis School of Veterinary Medicine hopes to help cure cancer in both people and pets.
Read More -
December 02, 2022Finding better ways to measure cognitive change in people with intellectual disability
A new UC Davis MIND Institute study finds the NIH Toolbox Cognition Battery is a promising option for measuring cognitive change in people with intellectual disability.
Read More
-
November 21, 2022Physicians urged to consider fungal infections as possible cause for lung inflammation
Infectious diseases expert George Thompson warns of the rising threat and apparent spread of disease-causing fungi outside their traditional hot spots. Fungal lung infections are commonly misdiagnosed, leading to delays in treatment and increase in antimicrobial resistance in the community.
Read More -
November 16, 2022NIH awards emergency medicine physicians two grants
The Department of Emergency Medicine has been awarded two National Institutes of Health grants totaling over $5 million to improve patient care. They include an effort to better evaluate pediatric trauma patients and another to identify effective treatments early in emergency care.
Read More -
November 15, 2022
Sacramento woman celebrates 100th clinical trial dose, cancer-free
A Sacramento woman celebrates the 100th dose of a clinical trial therapy that has left her cancer free. The Phase II clinical trial at UC Davis Comprehensive Cancer Center combines two immunotherapy drugs that lower toxicity and lengthen remission.
Read More -
November 07, 2022UC Davis gets $15 million to develop and assess AI for breast cancer detection, risk model
A team led by Diana Miglioretti, chief of biostatistics at UC Davis, won a $15 million NCI grant to develop models and use artificial intelligence to make breast cancer screening and surveillance more accurate and equitable.
Read More
-
October 21, 2022Study finds earlier mammograms for women with family history of breast cancer may not be needed
A UC Davis Comprehensive Cancer Center researcher helped lead a new study that may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
Read More -
October 19, 2022Study finds caregiver-child relationships improved after seven-session intervention
A new study by researchers at UC Davis Children’s Hospital uses the first randomized controlled trial to evaluate PC-CARE’s effectiveness for children with challenging behaviors and their parents or caregivers. The study’s findings were recently published in the Journal of Child Psychiatry Human Development.
Read More -
October 06, 2022What you need to know about shellfish allergy diagnosis, treatment
Shellfish is the leading cause of food allergy in the U.S. In this Q& A, Patrick Leung, professor of rheumatology, allergy and clinical immunology at UC Davis Health, answers questions on the latest advances in diagnosing and treating shellfish allergies.
Read More -
October 06, 2022
World’s first stem cell treatment for spina bifida delivered during fetal surgery
Three babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read More -
October 05, 2022When it comes to faces, context matters
Context shapes our perception of facial expressions during everyday social interactions. A recent UC Davis Health study identified where in the brain these neural computations take place and how, based on context, the different parts of the brain interact to determine facial perception.
Read More -
October 05, 2022Symposium at UC Davis showcases range of medical applications for light-based technologies
The National Center for Interventional Biophotonic Technologies hosted its inaugural symposium September 29 and 30, bringing together leading researchers from 13 institutions. The light-based technologies being developed have the potential to transform how diseases are diagnosed, managed, and treated.
Read More -
October 04, 2022UC Davis neuroscientist Sergey Stavisky wins 2022 NIH Director’s New Innovator Award
UC Davis Health neuroscientist Sergey Stavisky was selected by the National Institutes of Health to receive the 2022 NIH Director’s New Innovator Award. The $2.3 million award will fund his research on medical devices implanted in the brain to restore speech.
Read More
-
September 28, 2022CDC grant to study risks of combined use of opioids and ‘benzos’
UC Davis Health researchers received a $1.05 million grant from the Centers for Disease Control and Prevention to identify risk and protective factors linked to the combined use of opioids and benzodiazepines, a group of drugs used to treat anxiety and insomnia.
Read More -
September 23, 2022Uncovering the skin’s secrets: Studies show how skin forms differently across the body
Two recent UC Davis studies reveal how skin forms differently across different areas of the body from the face and underarms to the palms of our hands and feet. By profiling the changes in skin, researchers found that the differences have a direct impact for how various skin diseases form across the body.
Read More -
September 22, 2022Breaking the loop leading to muscular fibrosis
When an injury doesn’t heal correctly, fibrosis and scar tissue form in the muscles. A UC Davis team may have unlocked a way to prevent muscular fibrosis by preventing stem cells from getting stuck in an endless loop of collagen production.
Read More -
September 21, 2022UC Davis researchers explore new angle on pancreatic islet function
UC Davis researchers have shown for the first time that the signaling protein 14-3-3-zeta can shift pancreatic alpha cells from producing glucagon, which increases blood glucose, to make the antidiabetic hormone GLP-1. These findings could lead to new therapies for people with type 2 diabetes.
Read More -
September 21, 2022
Could monoclonal antibodies replace opioids for chronic pain?
During the pandemic, physicians used infusions of monoclonal antibodies to help patients fight off COVID-19 infections. Now, in response to the U.S. opioid crisis, researchers at UC Davis are trying to create monoclonal antibodies that can help fight chronic pain.
Read More -
September 13, 2022$4 million donation from Daryl Geweke supports glaucoma research and treatment
The Eye Center at UC Davis Health has two new endowed chairs focused on glaucoma research and treatment, thanks to a $4 million donation from business entrepreneur Daryl Geweke. James D. Brandt and Nicholas R. Marsh-Armstrong are the inaugural holders of the new endowed chairs.
Read More -
September 08, 2022UC Davis Health recruiting for study on using both implant, birth control pills
Are two birth control methods better than one? UC Davis Health is one of three centers in the United States, investigating if patients are willing to use both a birth control pill and a hormonal birth control implant at the same time.
Read More
